Apr 30 |
Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
|
Apr 29 |
Soleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To Watch
|
Apr 29 |
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
Apr 29 |
Why Soleno Therapeutics Stock Is Skyrocketing Today
|
Apr 29 |
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
|
Apr 29 |
Soleno Therapeutics receives breakthrough therapy designation from FDA for PWS treatment
|
Apr 29 |
Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
|
Apr 4 |
CEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)
|
Apr 4 |
Insider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)
|